Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01502748 · ClinicalTrials.gov registry record · NA

Endovascular Magnesium Sampling in Acute Stroke

A NA study, sponsored by University of Southern California.

Terminated
Registry status
NA
Development phase
2
Enrollment target

NCT01502748 is a NA study that was terminated before completion, run by University of Southern California. The registered enrollment target is 2 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01502748, a NA study, was terminated before completion, sponsored by University of Southern California.

TERMINATED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

This investigation will address the safety and feasibility of distal, intra-arterial sampling through endovascular access, in acute stroke patients. Levels of Magnesium will be measured in the region of infarct in patients who had been treated with intravenous Magnesium therapy following an acute stroke. This study attempts to address whether the traditional intravenous means of neuroprotectant administration achieves adequate concentration of the therapeutic agent in the area of diseased tissue.

Interventions

  • OTHER endovascular sampling

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2012-03
Est. Completion 2013-02
Phase NA

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT01502748

The ClinicalTrials.gov registry entry for NCT01502748 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which endovascular sampling is the first listed.

NCT01502748 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01502748 about?

NCT01502748 is a clinical study titled "Endovascular Magnesium Sampling in Acute Stroke". This investigation will address the safety and feasibility of distal, intra-arterial sampling through endovascular access, in acute stroke patients. Levels of Magnesium will be measured in the region of infarct in patients who had been treated with intravenous Magnesium therapy following an acute st...

What is the current status of trial NCT01502748?

This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2012-03. Estimated completion is 2013-02.

What interventions are being tested in trial NCT01502748?

The interventions under investigation include: endovascular sampling (OTHER).

Who is sponsoring clinical trial NCT01502748?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.